Categories: ALSForschungNews

AmbulanzPartner supports clinical study on the effects of physiotherapy in amyotrophic lateral sclerosis

Treatment with physiotherapy, occupational therapy and speech therapy are established and important forms of treatment for amyotrophic lateral sclerosis (ALS). Despite the “routine” use of these therapies, very little medical-scientific information is known about the results and subjective experiences in ALS.

So far, only three scientific publications on treatment results with physiotherapy in ALS are available. The number of patients examined in past studies is very low and amounts to less than 30 study patients. The Outpatient Clinic for ALS at Charité – Universitätsmedizin Berlin and AmbulanzPartner want to reduce this knowledge deficit with a “physiotherapy study”.


In July 2012, an evaluation of various forms of physical treatment for ALS (OR-PT-ALS01 study) was launched at Charité. An interim analysis in March 2013 revealed that more than 50 patients with ALS are already participating in the study.


The study procedure consists of patients being invited to complete a specific questionnaire on AmbulanzPartner.de at one-month intervals. During the study, the type, scope and frequency of the prescribed therapy are recorded and correlated with the information from the questionnaire.


Participation in this study is of great importance in order to be able to make more targeted recommendations on the method, frequency and duration of therapy in the coming months and years. Direct patient feedback plays a decisive role in this.


The involvement of the patient in the assessment of treatment outcomes (“patient-reported outcomes”; PRO) is a positive development in modern medicine, which is referred to as “goal-oriented” or “patient-centered” medicine.
admin

Recent Posts

The ALS app at the international ALS symposium in San Diego

On December 4, 2025, the ALS app will be presented at the"ALS App Europe Initiative…

2 months ago

Which ALS outpatient clinics use the OPM classification?

Following our last newsletter on the introduction of the OPM classification in the ALS app,…

2 months ago

Submit your e-prescription in the ALS app at your ALS pharmacy and continue to support ALS research

You can now submit your e-prescription with your health card via the ALS app at…

2 months ago

The new ALS-OPM classification is now in the ALS app.

We are pleased to introduce an important new feature in the ALS app today: The…

2 months ago

Patient survey on THC:CBD in people with ALS

The THC:CBD patient survey is a systematic survey of 130 patients with amyotrophic lateral sclerosis…

2 months ago

New medication module in the outpatient partner care portal

We are pleased to inform you that we have completely revised our medication module. With…

3 months ago